参考文献[1]
薛刘军,王丽君,欧洲,等.粪菌移植治疗帕金森病患者便秘的临床疗效[J].中华神经科杂志, 2019, 52(12):1054-1058. .
XueLJ, WangLJ, OuZ, et al. Clinical efficacy of fecal microbiota transplantation in treatment of Parkinson′s disease with constipation[J]. Chin J Neruol, 2019, 52(12): 1054-1058. .[3]
中华医学会神经病学分会神经心理与行为神经病学学组.常用神经心理认知评估量表临床应用专家共识[J].中华神经科杂志,2019, 52(3): 166-176. .
Chinese Society of Neuropsychology and Behavioral Neurology. Expert consensus on clinical application of neuropsychological cognitive assessment scales[J]. Chin J Neurol, 2019, 52(3): 166-176. .[4]
中华医学会神经病学分会,中华医学会神经病学分会神经血管介入协作组.介入神经病学导管室构建与管理中国专家共识[J].中华神经科杂志, 2019, 52(4): 247-251. .
Chinese Society of Neurology, Neurovascular Intervention Group of Chinese Society of Neurology. Chinese expert consensus on the construction and management of cerebrovascular intervention center[J]. Chin J Neurol, 2019, 52(4): 247-251. .[5]
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志, 2019, 52(4): 252-265. .
Chinese Society of Neurology, Chinese Stroke Society. Consensus on diagnosis and treatment of hemorrhagic transformation after acute ischemic stroke in China 2019[J]. Chin J Neurol, 2019, 52(4): 252-265. .[6]
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑血管病一级预防指南2019[J].中华神经科杂志, 2019, 52(9): 684-709. .
Chinese Society of Neurology, Chinese Stroke Society. Guidelines for the primary prevention of cerebrovascular diseases in China 2019[J]. Chin J Neurol, 2019, 52(9): 684-709. .[7]
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国各类主要脑血管病诊断要点2019[J].中华神经科杂志, 2019, 52(9): 710-715. .
Chinese Society of Neurology, Chinese Stroke Society. Diagnostic criteria of cerebrovascular diseases in China (version 2019)[J]. Chin J Neurol, 2019, 52(9): 710-715. .[8]
中华医学会神经病学分会,中华医学会神经病学分会周围神经病协作组,中华医学会神经病学分会肌电图与临床神经电生理学组,中华医学会神经病学分会神经肌肉病学组.中国吉兰-巴雷综合征诊治指南2019[J].中华神经科杂志, 2019, 52(11): 877-882. .
Chinese Society of Neurology, Peripheral Neuropathy Collaboration Group of Chinese Society of Neurology, Chinese Society of Electromyography and Clinical Neuroelectrophysiology, Chinese Society of Neuromuscular Disease. Chinese guidelines for diagnosis and treatment of Guillain-Barré syndrome 2019[J]. Chin J Neurol, 2019, 52(11): 877-882. .[9]
中华医学会神经病学分会,中华医学会神经病学分会周围神经病协作组,中华医学会神经病学分会肌电图与临床神经电生理学组,中华医学会神经病学分会神经肌肉病学组.中国慢性炎性脱髓鞘性多发性神经根神经病诊治指南2019[J].中华神经科杂志, 2019, 52(11): 883-888. .
Chinese Society of Neurology, Peripheral Neuropathy Collaboration Group of Chinese Society of Neurology, Chinese Society of Electromyography and Clinical Neuroelectrophysiology, Chinese Society of Neuromuscular Disease. Chinese guidelines for diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy 2019[J]. Chin J Neurol, 2019, 52(11): 883-888. .[10]
中华医学会神经病学分会,中华医学会神经病学分会周围神经病协作组,中华医学会神经病学分会肌电图与临床神经电生理学组,中华医学会神经病学分会神经肌肉病学组.中国多灶性运动神经病诊治指南2019[J].中华神经科杂志, 2019, 52(11): 889-892. .
Chinese Society of Neurology, Peripheral Neuropathy Collaboration Group of Chinese Society of Neurology, Chinese Society of Electromyography and Clinical Neuroelectrophysiology, Chinese Society of Neuromuscular Disease. Chinese guidelines for diagnosis and treatment of multifocal motor neuropathy 2019[J]. Chin J Neurol, 2019, 52(11): 889-892. .[11]
中华医学会神经病学分会,中华医学会神经病学分会周围神经病协作组,中华医学会神经病学分会肌电图与临床神经电生理学组,中华医学会神经病学分会神经肌肉病学组.中国POEMS综合征周围神经病变诊治专家共识[J].中华神经科杂志, 2019,52(11): 893-897. .
Chinese Society of Neurology, Peripheral Neuropathy Collaboration Group of Chinese Society of Neurology, Chinese Society of Electromyography and Clinical Neuroelectrophysiology, Chinese Society of Neuromuscular Disease. Chinese expert consensus on diagnosis and treatment of POEMS syndrome peripheral neuropathy[J]. Chin J Neurol, 2019, 52(11): 893-897. .[12]
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,中华医学会神经病学分会神经血管介入协作组.中国蛛网膜下腔出血诊治指南2019[J].中华神经科杂志, 2019, 52(12): 1006-1021. .
Chinese Society of Neurology, Chinese Stroke Society, Neurovascular Intervention Group of Chinese Society of Neurology. Chinese guidelines for diagnosis and treatment of subarachnoid hemorrhage 2019[J]. Chin J Neurol, 2019, 52(12): 1006-1021. .[13]
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,中华医学会神经病学分会神经血管介入协作组.中国脑出血诊治指南(2019)[J].中华神经科杂志, 2019, 52(12): 994-1005. .
Chinese Society of Neurology, Chinese Stroke Society, Neurovascular Intervention Group of Chinese Society of Neurology. Chinese guidelines for diagnosis and treatment of acute intracerebral hemorrhage 2019[J]. Chin J Neurol, 2019, 52(12): 994-1005. .[14]
焉传祝,温冰.脂肪沉积性肌病[J].中华神经科杂志, 2019, 52(2): 127-132. .
YanCZ, WenB. Lipid storage myopathy[J]. Chin J Neurol, 2019, 52(2): 127-132. .[15]
袁云.神经系统线粒体病[J].中华神经科杂志, 2019, 52(4): 327-333. .
YuanY. Neurological mitochondrial diseases[J]. Chin J Neurol, 2019, 52(4): 327-333. .[16]
蒲传强.特发性炎性肌病[J].中华神经科杂志, 2019, 52(5): 410-422. .
PuCQ. Idiopathic inflammatory myopathy[J]. Chin J Neurol, 2019, 52(5): 410-422. .[17]
胡静.抗肌萎缩蛋白病[J].中华神经科杂志, 2019, 52(6): 498-506. .
HuJ. Dystrophinopathy[J]. Chin J Neurol, 2019, 52(6): 498-506. .[18]
罗苏珊,卢家红.肢带型肌营养不良[J].中华神经科杂志, 2019, 52(7): 573-581. .
LuoSS, LuJH. Limb-girdle muscular dystrophy[J]. Chin J Neurol, 2019, 52(7): 573-581. .[19]
卜碧涛,李悦.强直性肌营养不良[J].中华神经科杂志, 2019, 52(8): 654-658. .
BuBT, LiY. Myotonic dystrophy[J]. Chin J Neurol, 2019, 52(8): 654-658. .[20]
崔丽英.临床神经电生理在肌萎缩侧索硬化中的应用[J].中华神经科杂志, 2019, 52(9): 765-769. .
CuiLY. Clinical application of electrophysiology in amyotrophic lateral sclerosis[J]. Chin J Neurol, 2019, 52(9): 765-769. .[21]
廉羚,姚晓黎.运动神经元病的鉴别诊断[J].中华神经科杂志, 2019, 52(10): 841-846. .
LianL, YaoXL. Differential diagnosis of motor neuron disease[J]. Chin J Neurol, 2019, 52(10): 841-846. .[22]
黄旭升,崔芳.肌萎缩侧索硬化的治疗[J].中华神经科杂志, 2019, 52(11): 952-956. .
HuangXS, CuiF. Therapies for amyotrophic lateral sclerosis[J]. Chin J Neurol, 2019, 52(11): 952-956. .[23]
樊东升,陈璐.运动神经元病的诊断和分类[J].中华神经科杂志, 2019, 52(12): 1065-1067. .
FanDS, ChenL. Diagnosis and classification of motor neuron disease[J]. Chin J Neurol, 2019, 52(12): 1065-1067. .[24]
邓波,章彤彤,陈向军,等.抗γ-氨基丁酸A型受体脑炎:以癫痫为突出表现的新型自身免疫性脑炎[J].中华神经科杂志, 2019, 52(2): 85-91. .
DengB, ZhangTT, ChenXJ, et al. Anti-γ-aminobutyric acid type A receptor encephalitis: a new type of autoimmune encephalitis with prominent epilepsy[J]. Chin J Neurol, 2019,52(2): 85-91. .[25]
赵玉英,焉传祝,亓法英,等.晚发型钴胺素C缺陷病临床及分子遗传学特点分析[J].中华神经科杂志, 2018, 51(11): 863-870. .
ZhaoYY, YanCZ, QiFY, et al. Characteristics of clinical manifestations and molecular genetics of late-onset cobalamin C deficiency[J]. Chin J Neurol, 2018, 51(11): 863-870. .[26]
张思怡,于裴夫,朱文清,等.跨膜蛋白175、三甲基巴豆酰辅酶A羧化酶和α-突触核蛋白基因的三个单核苷酸多态性与中国北方汉族帕金森病遗传易患性的相关性分析[J].中华神经科杂志, 2018, 51(7): 520-525. .
ZhangSY, YuPF, ZhuWQ, et al. A relevant research of connections between the genetic susceptibility of Parkinson′s disease and three single nucleotide polymorphisms in transmembrane protein 175, methylcrotonoyl-coenzyme A carboxylase 1 and alpha-synuclein in northern Chinese Han population[J]. Chin J Neurol, 2018, 51(7): 520-525. .[27]
中国科学技术信息研究所.中国科技期刊引证报告(核心版)[M].北京:科学技术文献出版社,2019.
Institute of Scientific and Technical Information of China. Chinese S&T journal citation report[M]. Beijing: Scientific and Technical Documentation Press, 2019.